Register Now
Course Information

Join Us at the 23rd Annual Diabetes Day

Diabetes Day: New Frontiers in Diabetes is a CME-certified educational symposium presented by the Cleveland Clinic Department of Endocrinology, Diabetes and Metabolism to provide up-to-date reviews of advances in management strategies for patients with diabetes. Key topic areas include the pathobiology of diabetes complications, new oral agents, diabetes control, and current guideline recommendations.

Attendees Will Learn How To:

  • Describe the pharmacologic actions, side effect profiles, clinical trial data, and potential role of recently approved drugs for treating diabetes and those in the pipeline
  • Summarize the effects of specific drug classes on glucose levels
  • Define the clinical factors differentiating between treating to target and treating to outcome
  • Describe the impact of individualizing hemoglobin A1C goals and evaluate the risk of hypoglycemia in diabetes management strategies
  • Compare the effectiveness of exercise plans and weight control plans in diabetes therapy
  • Summarize data on the effectiveness of various diets and their potential role in diabetes strategies

Who Should Attend?

This activity is designed for primary care physicians, endocrinologists, diabetes educators, nurses, nurse practitioners, physician assistants, dietitians, and other health care professionals who care for patients with diabetes.

About Cleveland Clinic Endocrinology and Metabolism Institute

Ranked third in the nation by U.S. News & World Report, the Endocrinology and Metabolism Institute (EMI) is committed to providing the highest quality health care for patients with diabetes, endocrine and metabolic disorders, and obesity. Our staff is dedicated to exploring ways to improve the care of these patients and to teaching the best methods for treating them.

Our institute caregivers work together to provide the finest care in the country. Over 30 staff physicians, 18 fellows, and more than 80 nurses, medical assistants, diabetes educators, secretaries, patient service representatives, coders, administrators and managers work in EMI’s departments and centers to ensure streamlined diagnosis and treatment of our patients. The institute includes the oldest subspecialty at Cleveland Clinic, and continues a steady rise to be among the best treatment providers of diabetes and endocrine conditions in the nation.

  • Describe the pharmacologic actions, side effect profiles, clinical trial data, and potential role of recently approved drugs for treating diabetes and those in the pipeline
  • Summarize the effects of specific drug classes on glucose levels
  • Define the clinical factors differentiating between treating to target and treating to outcome
  • Describe the impact of individualizing hemoglobin A1c goals and evaluate the risk of hypoglycemia in diabetes management strategies
  • Compare the effectiveness of exercise plans and weight control plans in diabetes therapy
  • Summarize data on the effectiveness of various diets and their potential role in diabetes strategies